Jeffrey S. Sabol

Person

Bridgewater, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrimidine hydrazide compounds as PGDS inhibitors
- Patent number 8,258,130
- Issue date Sep 4, 2012
- Sanofi
- Suzanne C Aldous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine amide compounds as PGDS inhibitors
- Patent number 8,202,863
- Issue date Jun 19, 2012
- Aventis Pharmaceuticals Inc.
- Suzanne C. Aldous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as P2X7 ion channel blockers
- Patent number 7,741,493
- Issue date Jun 22, 2010
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as P2X7 ion channel blockers
- Patent number 7,326,792
- Issue date Feb 5, 2008
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives as interleukin-4 gene expression inhibitors
- Patent number 7,169,925
- Issue date Jan 30, 2007
- Aventis Pharmaceuticals Inc.
- Gregory H. Merriman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for determining the potency, specificity, and toxicity of m...
- Patent number 7,132,256
- Issue date Nov 7, 2006
- Aventis Pharmaceuticals Inc.
- Yang Cao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS
- Publication number 20100048568
- Publication date Feb 25, 2010
- Sanofi-Aventis
- Suzanne C. Aldous
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS
- Publication number 20080227782
- Publication date Sep 18, 2008
- Aventis Pharmaceuticals Inc.
- Suzanne C. Aldous
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS P2X7 ION CHANNEL BLOCKERS
- Publication number 20080132550
- Publication date Jun 5, 2008
- Aventis Pharmaceuticals Inc.
- Patrick SHUM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for Determining the Potency, Specificity, and Toxicity of H...
- Publication number 20070259384
- Publication date Nov 8, 2007
- Aventis Pharmaceuticals Inc.
- Yang Cao
- G01 - MEASURING TESTING
Information Patent Application
Methods for determining the potency, specificity, and toxicity of m...
- Publication number 20060024663
- Publication date Feb 2, 2006
- Aventis Pharmaceuticals Inc.
- Yang Cao
- G01 - MEASURING TESTING
Information Patent Application
Heterocyclic compounds as P2X7 ion channel blockers
- Publication number 20050026916
- Publication date Feb 3, 2005
- Aventis Pharmaceuticals Inc.
- Patrick Shum
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method for assaying compounds or agents for ability to decrease the...
- Publication number 20040082021
- Publication date Apr 29, 2004
- Aventis Pharmaceuticals Inc.
- Zhuyin Li
- G01 - MEASURING TESTING
Information Patent Application
Indole derivatives as interleukin -4 gene expression inhibitors
- Publication number 20040010029
- Publication date Jan 15, 2004
- Gregory H. Merriman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jeffrey S. Sabol

Person

Patents Grantslast 30 patents

Pyrimidine hydrazide compounds as PGDS inhibitors

Pyrimidine amide compounds as PGDS inhibitors

Heterocyclic compounds as P2X7 ion channel blockers

Heterocyclic compounds as P2X7 ion channel blockers

Indole derivatives as interleukin-4 gene expression inhibitors

Methods for determining the potency, specificity, and toxicity of m...

Patents Applicationslast 30 patents

PYRIMIDINE HYDRAZIDE COMPOUNDS AS PGDS INHIBITORS

PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS

HETEROCYCLIC COMPOUNDS AS P2X7 ION CHANNEL BLOCKERS

Methods for Determining the Potency, Specificity, and Toxicity of H...

Methods for determining the potency, specificity, and toxicity of m...

Heterocyclic compounds as P2X7 ion channel blockers

Method for assaying compounds or agents for ability to decrease the...

Indole derivatives as interleukin -4 gene expression inhibitors